Literature DB >> 19081647

Incident coronary revascularization and subsequent mortality in chronic heart failure: a propensity-matched study.

Grigorios Giamouzis1, Syed Abbas Agha, O James Ekundayo, Inmaculada Aban, Thomas E Love, Casey Daniel, Javed Butler, Ali Ahmed.   

Abstract

INTRODUCTION: Ischemic heart disease (IHD) is common in heart failure (HF), yet the association between incident coronary revascularization and mortality in these patients has not been examined in a propensity-matched study.
METHODS: In the Digitalis Investigation Group trial, 2853 patients without coronary revascularization and 120 patients with coronary revascularization during the first three years were alive at the end of three years. We used propensity scores to match 119 and 357 patients with and without coronary revascularization. Matched Cox regression models were used to estimate hazard ratio (HR) and 95% confidence interval (CI) for mortality during the fourth year of follow-up, for all patients and by the mean left ventricular ejection fraction (LVEF) of 35%.
RESULTS: Coronary revascularization was associated with higher mean LVEF (36% versus 32%; p<0.0001) and prevalence of angina pectoris (48% versus 32%; p<0.0001) but fewer prior myocardial infarction (80% versus 87%; p=0.023), all of which were balanced post-match. All-cause mortality occurred in 5.9% and 6.2% patients respectively with and without coronary revascularization (HR for coronary revascularization, 0.95; 95% CI, 0.39-2.32; p=0.910). HR for mortality associated with coronary revascularization for patients with LVEF < or = 35% and >35% were respectively 1.34 (95% CI, 0.48-3.71; p=0.578) and 0.61 (95% CI, 0.13-2.87; p=0.532).
CONCLUSION: Chronic HF patients with IHD receiving coronary revascularization were more likely to have angina and higher LVEF. However, in a balanced propensity-matched cohort, there was no association between coronary revascularization and mortality. The LVEF-associated variation in mortality needs to be prospectively studied. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Year:  2008        PMID: 19081647      PMCID: PMC2904513          DOI: 10.1016/j.ijcard.2008.10.049

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  27 in total

1.  Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores.

Authors:  S T Normand; M B Landrum; E Guadagnoli; J Z Ayanian; T J Ryan; P D Cleary; B J McNeil
Journal:  J Clin Epidemiol       Date:  2001-04       Impact factor: 6.437

2.  Eighteen-year follow-up in the Veterans Affairs Cooperative Study of Coronary Artery Bypass Surgery for stable angina.

Authors: 
Journal:  Circulation       Date:  1992-07       Impact factor: 29.690

3.  Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis.

Authors:  Kevin C Allman; Leslee J Shaw; Rory Hachamovitch; James E Udelson
Journal:  J Am Coll Cardiol       Date:  2002-04-03       Impact factor: 24.094

4.  Long-term outcome and the use of revascularization in patients with heart failure, suspected ischemic heart disease, and large reversible myocardial perfusion defects.

Authors:  Wayne L Miller; Susan K Tointon; David O Hodge; Susan M Nelson; Richard J Rodeheffer; Raymond J Gibbons
Journal:  Am Heart J       Date:  2002-05       Impact factor: 4.749

5.  Results of revascularization in patients with severe left ventricular dysfunction.

Authors:  L L Mickleborough; S Carson; M Tamariz; J Ivanov
Journal:  J Thorac Cardiovasc Surg       Date:  2000-03       Impact factor: 5.209

6.  Early versus delayed revascularization in patients with ischemic cardiomyopathy and substantial viability: impact on outcome.

Authors:  Jeroen J Bax; Arend F L Schinkel; Eric Boersma; Vittoria Rizzello; Abdou Elhendy; Alexander Maat; Jos R T C Roelandt; Ernst E van der Wall; Don Poldermans
Journal:  Circulation       Date:  2003-09-09       Impact factor: 29.690

7.  Determination of vital status at the end of the DIG trial.

Authors:  Joseph F Collins; Cindy L Howell; R Anne Horney
Journal:  Control Clin Trials       Date:  2003-12

8.  Microvascular angina pectoris in hypertensive patients with left ventricular hypertrophy and diagnostic value of exercise thallium-201 scintigraphy.

Authors:  M Iriarte; R Caso; N Murga; J M Faus; D Sagastagoitia; E Molinero; M López de Argumedo; J Boveda
Journal:  Am J Cardiol       Date:  1995-02-15       Impact factor: 2.778

9.  Congestive heart failure from left ventricular diastolic dysfunction in systemic hypertension.

Authors:  M Iriarte; N Murga; D Sagastagoitia; E Molinero; M Morillas; A Salcedo; P Estella; J Etxebeste
Journal:  Am J Cardiol       Date:  1993-02-01       Impact factor: 2.778

10.  Survival following coronary artery bypass grafting in patients with severe angina pectoris (CASS). An observational study.

Authors:  G C Kaiser; K B Davis; L D Fisher; W O Myers; E D Foster; E R Passamani; M J Gillespie
Journal:  J Thorac Cardiovasc Surg       Date:  1985-04       Impact factor: 5.209

View more
  7 in total

1.  Design and rationale of studies of neurohormonal blockade and outcomes in diastolic heart failure using OPTIMIZE-HF registry linked to Medicare data.

Authors:  Yan Zhang; Meredith L Kilgore; Tarun Arora; Marjan Mujib; O James Ekundayo; Inmaculada B Aban; Margaret A Feller; Ravi V Desai; Thomas E Love; Richard M Allman; Gregg C Fonarow; Ali Ahmed
Journal:  Int J Cardiol       Date:  2011-11-25       Impact factor: 4.164

2.  Outcomes in younger and older adults with chronic advanced systolic heart failure: a propensity-matched study.

Authors:  Mustafa I Ahmed; Marjan Mujib; Ravi V Desai; Margaret A Feller; Casey Daniel; Inmaculada B Aban; Thomas E Love; Prakash Deedwania; Bertram Pitt; Wilbert S Aronow; Ali Ahmed
Journal:  Int J Cardiol       Date:  2010-10-14       Impact factor: 4.164

3.  Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease.

Authors:  Ali Ahmed; Gregg C Fonarow; Yan Zhang; Paul W Sanders; Richard M Allman; Donna K Arnett; Margaret A Feller; Thomas E Love; Inmaculada B Aban; Raynald Levesque; O James Ekundayo; Louis J Dell'Italia; George L Bakris; Michael W Rich
Journal:  Am J Med       Date:  2012-02-07       Impact factor: 4.965

4.  Gender-related dissociation in outcomes in chronic heart failure: reduced mortality but similar hospitalization in women.

Authors:  Mustafa I Ahmed; Mitja Lainscak; Marjan Mujib; Thomas E Love; Inmaculada Aban; Ileana L Piña; Wilbert S Aronow; Vera Bittner; Ali Ahmed
Journal:  Int J Cardiol       Date:  2009-11-24       Impact factor: 4.164

5.  Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: findings from a population-based cohort study.

Authors:  Prakash Deedwania; Kanan Patel; Gregg C Fonarow; Ravi V Desai; Yan Zhang; Margaret A Feller; Fernando Ovalle; Thomas E Love; Inmaculada B Aban; Marjan Mujib; Mustafa I Ahmed; Stefan D Anker; Ali Ahmed
Journal:  Int J Cardiol       Date:  2013-05-31       Impact factor: 4.164

6.  Current status of mechanical circulatory support: a systematic review.

Authors:  Kyriakos Spiliopoulos; Gregory Giamouzis; George Karayannis; Dimos Karangelis; Stelios Koutsias; Andreas Kalogeropoulos; Vasiliki Georgiopoulou; John Skoularigis; Javed Butler; Filippos Triposkiadis
Journal:  Cardiol Res Pract       Date:  2012-08-26       Impact factor: 1.866

7.  Telemonitoring in chronic heart failure: a systematic review.

Authors:  Gregory Giamouzis; Dimos Mastrogiannis; Konstantinos Koutrakis; George Karayannis; Charalambos Parisis; Chris Rountas; Elias Adreanides; George E Dafoulas; Panagiotis C Stafylas; John Skoularigis; Sara Giacomelli; Zoran Olivari; Filippos Triposkiadis
Journal:  Cardiol Res Pract       Date:  2012-06-07       Impact factor: 1.866

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.